Want to join the conversation?
$GILD 2Q15 Q&A: Mark of Evercore questioned on Gilead’s thoughts on acquisitions, and John said GILD is in terrific shape with strong workforce and balance sheet, and great scientific expertise on board, giving it the capability to do a wide range of things. GILD will be fairly selective in terms of the things it likes to do, he added.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?